ATE300286T1 - Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben - Google Patents

Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben

Info

Publication number
ATE300286T1
ATE300286T1 AT00978993T AT00978993T ATE300286T1 AT E300286 T1 ATE300286 T1 AT E300286T1 AT 00978993 T AT00978993 T AT 00978993T AT 00978993 T AT00978993 T AT 00978993T AT E300286 T1 ATE300286 T1 AT E300286T1
Authority
AT
Austria
Prior art keywords
polymers
dosage forms
pharmaceutical dosage
stomach
mixtures
Prior art date
Application number
AT00978993T
Other languages
English (en)
Inventor
Michael Friedman
Eytan Klausner
Eran Lavy
Amnon Hoffman
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Application granted granted Critical
Publication of ATE300286T1 publication Critical patent/ATE300286T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00978993T 1999-11-29 2000-11-20 Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben ATE300286T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL13319699A IL133196A0 (en) 1999-11-29 1999-11-29 Gastroretentive controlled release pharmaceutical dosage forms
PCT/IL2000/000774 WO2001037812A2 (en) 1999-11-29 2000-11-20 Gastroretentive controlled release pharmaceutical dosage forms

Publications (1)

Publication Number Publication Date
ATE300286T1 true ATE300286T1 (de) 2005-08-15

Family

ID=11073546

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00978993T ATE300286T1 (de) 1999-11-29 2000-11-20 Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben

Country Status (12)

Country Link
US (1) US6685962B2 (de)
EP (1) EP1235557B1 (de)
JP (1) JP4679020B2 (de)
AT (1) ATE300286T1 (de)
AU (1) AU783062B2 (de)
CA (1) CA2392361C (de)
DE (1) DE60021604T2 (de)
ES (1) ES2243327T3 (de)
IL (2) IL133196A0 (de)
RU (1) RU2002114348A (de)
WO (1) WO2001037812A2 (de)
ZA (1) ZA200204268B (de)

Families Citing this family (90)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040219186A1 (en) * 2001-08-16 2004-11-04 Ayres James W. Expandable gastric retention device
TWI312285B (en) * 2001-10-25 2009-07-21 Depomed Inc Methods of treatment using a gastric retained gabapentin dosage
AUPR951501A0 (en) * 2001-12-14 2002-01-24 Smart Drug Systems Inc Modified sustained release pharmaceutical system
US20040192582A1 (en) * 2002-12-19 2004-09-30 Burnett Daniel R. Ingestible formulations for transient, noninvasive reduction of gastric volume
US7554452B2 (en) * 2003-07-18 2009-06-30 Cary Cole Ingestible tracking and locating device
EP1660153A2 (de) * 2003-09-04 2006-05-31 The United States of America as represented by the Department of Veterans Affairs Hydrogel-nanokomposite für ophthalmische anwendungen
WO2005030179A1 (en) * 2003-09-29 2005-04-07 Cj Corporation Sustained-release formulations
CA2549195A1 (en) * 2003-12-09 2005-06-23 Spherics, Inc. Bioadhesive polymers with catechol functionality
US20080089933A1 (en) 2006-10-16 2008-04-17 Amir Alon Device and method for reducing calorie intake
US20050196355A1 (en) * 2004-03-03 2005-09-08 Constantine Georgiades Film products having controlled disintegration properties
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
DE602005025755D1 (de) 2004-06-04 2011-02-17 Teva Pharma Irbesartan enthaltende pharmazeutische zusammensetzung
US20080311191A1 (en) * 2004-08-27 2008-12-18 Avinash Nangia Multi-Layer Tablets and Bioadhesive Dosage Forms
MX2007007836A (es) * 2004-12-27 2007-08-20 Eisai R&D Man Co Ltd Metodo para estabilizar un farmaco anti-demencia.
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20070129402A1 (en) * 2004-12-27 2007-06-07 Eisai Research Institute Sustained release formulations
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
IL166183A0 (en) * 2005-01-06 2006-01-15 Yissum Res Dev Co Novel diagnostic and imaging techniques of the gi tract
WO2006088305A1 (en) * 2005-02-15 2006-08-24 Chong Kun Dang Pharmaceutical Corp. Gastric-retentive controlled release mono-matrix tablet
EP1933811A2 (de) * 2005-09-30 2008-06-25 Alza Corporation Gebundene nanoteilchenförmige dosierformen einer wirkstoffformulierung mit kontrollierter freisetzung und verfahren
US20070092565A1 (en) * 2005-10-25 2007-04-26 Pharmascience Inc. Gastric retention drug delivery system
EP2997953B1 (de) * 2006-01-18 2018-12-26 Intec Pharma Ltd. Ausgabevorrichtung zur oralen einnahme eines wirkstoffs
WO2007093999A1 (en) * 2006-02-15 2007-08-23 Intec Pharma Ltd. A gastro-retentive system for the delivery of macromolecules
EP2086515A2 (de) * 2006-03-02 2009-08-12 Vaunnex, Inc. Bioadhäsive orale darreichungsformen mit kontrollierter freigabe
PE20080669A1 (es) * 2006-09-08 2008-07-18 Drugtech Corp Composicion de liberacion sostenida que comprende levodopa
EP2124884B1 (de) 2006-12-22 2019-07-10 Ironwood Pharmaceuticals, Inc. Zusammensetzung mit gallensäurekomplexbildnern zur behandlung von erkrankungen der speiseröhre
WO2008115597A2 (en) * 2007-03-21 2008-09-25 Cytologic, Inc. Cytokine muteins and methods for enhancing immune responses in mammals
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
WO2009064814A2 (en) 2007-11-12 2009-05-22 Pharmaceutics International, Inc. Tri-molecular complexes and their use in drug delivery systems
CN102149369B (zh) 2008-04-18 2016-08-10 因泰克制药有限公司 卡比多巴/左旋多巴胃滞留给药
US7981760B2 (en) * 2008-05-08 2011-07-19 Panasonic Corporation Method for manufacturing nonvolatile storage element and method for manufacturing nonvolatile storage device
US8287902B2 (en) * 2008-07-23 2012-10-16 Rainbow Medical Ltd. Enhanced-diffusion capsule
CA2745741A1 (en) 2008-12-04 2010-06-10 Intec Pharma Ltd. Zaleplon gastroretentive drug delivery system
CN102481276A (zh) 2009-04-20 2012-05-30 埃尔舍利克斯治疗公司 基于化学感受受体配体的治疗法
US8828953B2 (en) * 2009-04-20 2014-09-09 NaZura BioHealth, Inc. Chemosensory receptor ligand-based therapies
US9901551B2 (en) 2009-04-20 2018-02-27 Ambra Bioscience Llc Chemosensory receptor ligand-based therapies
US8414559B2 (en) * 2009-05-07 2013-04-09 Rainbow Medical Ltd. Gastroretentive duodenal pill
US20100286628A1 (en) * 2009-05-07 2010-11-11 Rainbow Medical Ltd Gastric anchor
US20110066175A1 (en) * 2009-05-07 2011-03-17 Rainbow Medical Ltd. Gastric anchor
EP2490677A2 (de) * 2009-10-19 2012-08-29 Intec Pharma Ltd. Neue gastroretentive dosierungsformen schwach löslicher arzneimittel
CN106913902A (zh) 2009-11-09 2017-07-04 聚光灯技术合伙有限责任公司 多糖基水凝胶
CN102695501A (zh) 2009-11-09 2012-09-26 聚光灯技术合伙有限责任公司 碎裂水凝胶
WO2011073968A1 (en) * 2009-12-18 2011-06-23 Vysera Biomedical Limited A drug delivery system
ES2671551T3 (es) 2009-12-18 2018-06-07 Coloplast A/S Un biomaterial
EP2544666A2 (de) 2010-03-09 2013-01-16 Council of Scientific and Industrial Research Gastroretentive retard-zusammensetzung eines therapeutikums
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
MX2013004364A (es) 2010-10-19 2013-07-02 Elcelyx Therapeutics Inc Terapias a base de ligando del receptor quimiosensorial.
EP2661266B1 (de) 2011-01-07 2020-09-16 Anji Pharma (US) LLC Auf chemosensorischen rezeptorliganden basierende therapien
US8722066B2 (en) 2011-03-29 2014-05-13 Primigenia, LLC Devices and methods for weight control and weight loss
US20130143867A1 (en) 2011-12-02 2013-06-06 Sychroneuron Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2013158928A2 (en) 2012-04-18 2013-10-24 Elcelyx Therapeutics, Inc. Chemosensory receptor ligand-based therapies
WO2014039951A1 (en) 2012-09-10 2014-03-13 Novartis Ag Enteral pharmaceutical compositions
EP2988729A1 (de) * 2013-04-25 2016-03-02 Sun Pharmaceutical Industries Limited Magensaftresistente pharmazeutische feste orale darreichungsform von nilotinib
WO2014197744A1 (en) 2013-06-05 2014-12-11 Synchroneuron, Inc. Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2015091885A2 (en) * 2013-12-20 2015-06-25 Fresenius Kabi Deutschland Gmbh Microcapsules with polymeric coating comprising a lipid and an active agent
WO2015187746A1 (en) 2014-06-02 2015-12-10 Teva Pharmaceutical Industries Ltd. Expandable gastroretentive dosage form
NZ727659A (en) 2014-06-11 2021-12-24 Massachusetts Inst Technology Residence structures and related methods
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
US9492396B2 (en) 2014-07-15 2016-11-15 Yossi Gross Enhanced drug delivery pill
AU2016272089B2 (en) * 2015-06-03 2021-02-18 Triastek, Inc. Dosage forms and use thereof
CN108721242B (zh) * 2015-06-03 2021-03-02 南京三迭纪医药科技有限公司 药品剂型及其使用
MX387092B (es) 2015-06-17 2025-03-19 Biogen Ma Inc Particulas de dimetilfumarato y composiciones farmaceuticas de estas.
US11576859B2 (en) 2015-10-23 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained release of therapeutic agents and methods of use thereof
US11478427B2 (en) * 2015-10-26 2022-10-25 Aron H. Blaesi Dosage form comprising structural framework of two-dimensional elements
EP3368010B1 (de) * 2015-10-26 2025-12-10 Blaesi, Aron H. Feste dosierungsform für sofortige wirkstofffreisetzung sowie vorrichtung und verfahren zur herstellung davon
US11129798B2 (en) 2016-08-19 2021-09-28 Aron H. Blaesi Fibrous dosage form
CA3006999A1 (en) * 2015-12-01 2017-06-08 Clexio Biosciences Ltd. Gastric retentive devices
CA3007165A1 (en) * 2015-12-02 2017-06-08 Clexio Biosciences Ltd. Device for preparing gastroretentive dosage forms
WO2017100367A1 (en) 2015-12-08 2017-06-15 Lyndra, Inc. Geometric configurations for gastric residence systems
CA3017797A1 (en) 2016-03-17 2017-09-21 Thiogenesis Therapeutics, Inc. Compositions for controlled release of cysteamine and systemic treatment of cysteamine sensitive disorders
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity
CN109310639A (zh) 2016-05-27 2019-02-05 林德拉有限公司 用于胃驻留系统的材料结构
BR112018077541A2 (pt) * 2016-07-11 2019-04-30 Intec Pharma Ltd. formulações orais gastrorretentivas e usos das mesmas
JP2019532947A (ja) 2016-09-30 2019-11-14 リンドラ，インコーポレイティド アダマンタン系薬物の持続的送達のための胃内滞留システム
CN110035718B (zh) 2016-12-02 2021-04-06 克雷西奥生物科技有限公司 胃内滞留系统
EP3573602A4 (de) 2017-01-26 2020-09-16 Triastek, Inc. Dosierungsformen mit kontrollierter freisetzung an bestimmten gastrointestinalen orten
CA3066658A1 (en) 2017-06-09 2018-12-13 Lyndra, Inc. Gastric residence systems with release rate-modulating films
CA3076392A1 (en) 2017-09-20 2019-03-28 Thiogenesis Therapeutics, Inc. Methods for the treatment of cysteamine sensitive disorders
WO2019111132A1 (en) 2017-12-04 2019-06-13 Clexio Biosciences Ltd. Long acting gastric residence system
CN116270513A (zh) 2018-01-09 2023-06-23 南京三迭纪医药科技有限公司 一种包含固定剂量adhd非兴奋剂和adhd兴奋剂的复方口服药物剂型
US11911513B2 (en) 2018-05-23 2024-02-27 Shanghai Wd Pharmaceutical Co., Ltd Controlled-release system of active pharmaceutical ingredient and preparation method therefor
JP7125791B2 (ja) 2018-05-23 2022-08-25 シャンハイ ダブリュディー ファーマシューティカル カンパニー，リミティド 活性薬物成分の放出制御システムおよびその製造方法
CN114191307A (zh) 2020-09-17 2022-03-18 上海汉都医药科技有限公司 一种口腔滞留装置及其制备方法
US10675248B2 (en) 2018-08-14 2020-06-09 Alma Therapeutics Ltd. Expandable pill
HUE067496T2 (hu) 2020-12-08 2024-10-28 Ruminant Biotech Corp Ltd Az állatoknak szánt anyagok bejuttatására szolgáló eszközök és módszerek fejlesztése
KR20230159878A (ko) 2021-05-20 2023-11-22 이 잉크 코포레이션 전기 도금을 사용하는 유익 제제 전달 시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3574820A (en) 1968-01-08 1971-04-13 Upjohn Co Medicinal dosage forms of unpolymerized thiolated gelatin with a cross-linking accelerating agent providing slowly released medication from a swollen matrix
US4207890A (en) 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
US4434153A (en) 1982-03-22 1984-02-28 Alza Corporation Drug delivery system comprising a reservoir containing a plurality of tiny pills
US4735804A (en) 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US5002772A (en) 1988-05-31 1991-03-26 Pfizer Inc. Gastric retention system for controlled drug release
US5217712A (en) 1989-09-20 1993-06-08 Merck & Co., Inc. Bioerodible thermoset elastomers
US5047464A (en) 1989-09-20 1991-09-10 Merck & Co., Inc. Bioerodible thermoset elastomers
IT1265240B1 (it) * 1993-11-30 1996-10-31 Ekita Investments Nv Compressa farmaceutica a rilascio controllato, di forma lenticolare
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
US5840332A (en) * 1996-01-18 1998-11-24 Perio Products Ltd. Gastrointestinal drug delivery system

Also Published As

Publication number Publication date
AU1647701A (en) 2001-06-04
DE60021604T2 (de) 2006-06-01
CA2392361A1 (en) 2001-05-31
ES2243327T3 (es) 2005-12-01
US6685962B2 (en) 2004-02-03
EP1235557A2 (de) 2002-09-04
RU2002114348A (ru) 2004-01-10
JP2003514845A (ja) 2003-04-22
IL149853A (en) 2006-12-31
EP1235557B1 (de) 2005-07-27
WO2001037812A3 (en) 2002-02-21
JP4679020B2 (ja) 2011-04-27
US20030021845A1 (en) 2003-01-30
CA2392361C (en) 2010-01-19
AU783062B2 (en) 2005-09-22
DE60021604D1 (de) 2005-09-01
IL133196A0 (en) 2001-03-19
ZA200204268B (en) 2003-08-28
WO2001037812A2 (en) 2001-05-31

Similar Documents

Publication Publication Date Title
ATE300286T1 (de) Gastroretentive pharmazeutische dosierungsformen mit gesteuerten abgaben
Debotton et al. Applications of polymers as pharmaceutical excipients in solid oral dosage forms
CA2446712C (en) System for osmotic delivery of pharmaceutically active agents
US7674480B2 (en) Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
DE69009755D1 (de) Orale heilmittelform für dauerverabreichung.
ATE477795T1 (de) Magenretentionssystem mit kontrollierter arzneimittelfreisetzung
HRP20161433T1 (hr) Doprema lijeka zadržavanjem u želucu za karbidopa/levodopa
DE69122751D1 (de) Arzneimittelzusammensetzung mit kontrollierter wirkstoffabgabe
ES2162874T3 (es) Composicion farmaceutica para hacer llegar medicamentos hasta el colon.
CA2531833A1 (en) Poly-4-hydroxybutyrate matrices for sustained drug delivery
PT93170B (pt) Processo para a preparacao de dispositivos distribuidores nomeadamente, de capsulas contendo um ingrediente activo
ATE264666T1 (de) Im magen verweilendes arzneimittel mit verzögerter wirkstoffabgabe
ATE264670T1 (de) Eine pharmazeutische tablette charakterisiert durch hohen volumenzuwachs bei kontakt mit biologischen flüssigkeiten
WO2003051304A3 (en) Bioadhesive drug delivery system with enhanced gastric retention
NZ503820A (en) A delayed followed by immediate release drug delivery system containing a core and a coating
ATE269709T1 (de) Tablette mit verzögerter freigabe enthaltend einen blutzuckersenkenden wirkstoff und einen antihyperglyzemischen wirkstoff
BG102438A (en) Medicamentous form
AU2002303897A1 (en) System for osmotic delivery of pharmaceutically active agents
CA2509976A1 (en) Modified release pharmaceutical composition
JPH0624959A (ja) 胃内浮遊型薬物徐放性固形製剤
KR920703022A (ko) 가용성 또는 불용성 약물의 전달을 위한 제형
DE60041691D1 (de) Ph-unabhängige pharmazeutische formulierungen mit verlängerter freisetzung
Park et al. Polymers in pharmaceutical products
Collette et al. Triblock Copolymers Self-Assembled in Vesicles: Applications to the Oral Delivery of Insulin
EP0375649A3 (de) Perorales quellungskontrolliertes System für die Übergabe von Arzneimitteln

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties